Report Detail
Global (United States, European Union and China) Tumor Necrosis Factor Receptor Superfamily Member 18 Market Research Report 2019-2025
- RnM3374131 |
- 02 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Tumor Necrosis Factor Receptor Superfamily Member 18 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tumor Necrosis Factor Receptor Superfamily Member 18.
This report studies the global market size of Tumor Necrosis Factor Receptor Superfamily Member 18, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tumor Necrosis Factor Receptor Superfamily Member 18 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Market Segment by Product Type
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others
Market Segment by Application
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Tumor Necrosis Factor Receptor Superfamily Member 18 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tumor Necrosis Factor Receptor Superfamily Member 18 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Tumor Necrosis Factor Receptor Superfamily Member 18 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Growth Rate by Type (2019-2025)
- 1.3.2 AMG-228
- 1.3.3 BMS-986156
- 1.3.4 FPA-154
- 1.3.5 GWN-323
- 1.3.6 INCAGN-1876
- 1.3.7 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application (2019-2025)
- 1.4.2 Melanoma
- 1.4.3 Non-Small Cell Lung Cancer
- 1.4.4 Gastric Cancer
- 1.4.5 Blood Cancer
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size
- 2.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2014-2025
- 2.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2014-2025
- 2.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Growth Rate by Regions
- 2.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Regions 2014-2019
- 2.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers
- 3.1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturers 2014-2019
- 3.1.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturers (2014-2019)
- 3.2.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Concentration Ratio (CR5 and HHI)
- 3.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturers
- 3.4 Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 18 Market
- 3.6 Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 AMG-228 Sales and Revenue (2014-2019)
- 4.1.2 BMS-986156 Sales and Revenue (2014-2019)
- 4.1.3 FPA-154 Sales and Revenue (2014-2019)
- 4.1.4 GWN-323 Sales and Revenue (2014-2019)
- 4.1.5 INCAGN-1876 Sales and Revenue (2014-2019)
- 4.1.6 Others Sales and Revenue (2014-2019)
- 4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type
- 4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type
- 4.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application
6 United States
- 6.1 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Company
- 6.2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Type
- 6.3 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Application
7 European Union
- 7.1 European Union Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Company
- 7.2 European Union Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Type
- 7.3 European Union Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Application
8 China
- 8.1 China Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Company
- 8.2 China Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Type
- 8.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Company
- 9.2 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Type
- 9.3 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Application
- 9.4 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Countries
- 9.4.1 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Countries
- 9.4.2 Rest of World Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Ablynx NV
- 10.1.1 Ablynx NV Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.1.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.1.5 Ablynx NV Recent Development
- 10.2 Amgen Inc
- 10.2.1 Amgen Inc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.2.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.2.5 Amgen Inc Recent Development
- 10.3 Apogenix GmbH
- 10.3.1 Apogenix GmbH Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.3.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.3.5 Apogenix GmbH Recent Development
- 10.4 Bristol-Myers Squibb Company
- 10.4.1 Bristol-Myers Squibb Company Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.4.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.4.5 Bristol-Myers Squibb Company Recent Development
- 10.5 Five Prime Therapeutics Inc
- 10.5.1 Five Prime Therapeutics Inc Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.5.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.5.5 Five Prime Therapeutics Inc Recent Development
- 10.6 Incyte Corp
- 10.6.1 Incyte Corp Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.6.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.6.5 Incyte Corp Recent Development
- 10.7 MedImmune LLC
- 10.7.1 MedImmune LLC Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.7.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.7.5 MedImmune LLC Recent Development
- 10.8 Merck & Co Inc
- 10.8.1 Merck & Co Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.8.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.8.5 Merck & Co Inc Recent Development
- 10.9 Novartis AG
- 10.9.1 Novartis AG Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.9.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.9.5 Novartis AG Recent Development
- 10.10 OncoMed Pharmaceuticals Inc
- 10.10.1 OncoMed Pharmaceuticals Inc Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Tumor Necrosis Factor Receptor Superfamily Member 18
- 10.10.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Product Introduction
- 10.10.5 OncoMed Pharmaceuticals Inc Recent Development
- 10.11 Regeneron Pharmaceuticals Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Channels
- 11.2.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors
- 11.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Customers
12 Market Forecast
- 12.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue Forecast 2019-2025
- 12.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type
- 12.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application
- 12.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Forecast by Regions
- 12.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Regions 2019-2025
- 12.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Tumor Necrosis Factor Receptor Superfamily Member 18 . Industry analysis & Market Report on Tumor Necrosis Factor Receptor Superfamily Member 18 is a syndicated market report, published as Global (United States, European Union and China) Tumor Necrosis Factor Receptor Superfamily Member 18 Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
